Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

US Administration Expands Availability of COVID Antiviral Pill

President Joe Biden's administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid, as it seeks to reassure doctors that there is ample supply for people at high risk of severe illness or death from the virus. Paxlovid, produced by Pfizer, was first approved in December.…

Asharq Al-Awsat

Administration expands availability of COVID antiviral pill

President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid

The Independent UK

Poor nations left behind on vaccines

"Do not let history repeat itself," advocates warn as low-income countries lack access to Pfizer treatment

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Pass urgent COVID funding or more will die, White House says

After two years at the front of the line for COVID-19 vaccines and treatments, the U.S. could soon have to begin taking a number

The Independent UK

Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters

Poland can compromise with Moderna Inc (NASDAQ:MRNA) on increasing the flexibility of COVID-19 vaccine contracts, Reuters reported citing the health minister, striking an upbeat tone after initial talks with the company. Poland has said it will not take or pay for more doses of the COVID-19 vaccine under the European Union's supply contract. Reuters…

Benzinga

Pfizer Recalls Some Batches Of Another Hypertension Drug Over Cancer-Causing Impurity

Pfizer Inc (NYSE:PFE) said it is voluntarily recalling five batches of its Accupril blood pressure tablets after finding elevated levels of a potential cancer-causing agent in the medicine. Accupril is indicated for hypertension to lower blood pressure. It is also indicated for the management of heart failure as adjunctive therapy when added to…

Benzinga

The quest for a coronavirus supervaccine

PARIS: As vaccine makers rush to stamp out new Covid-19 variants, some scientists have set their sights higher, aiming for a universal coronavirus vaccine that could tackle any future strains and possibly even stave off another pandemic.

Bangkok Post

Read news from The Economist, FT, and more,
with one subscription

COVID shots still work but researchers hunt new improvements

COVID-19 vaccines still offer strong protection against severe illness and death, but Moderna and Pfizer are testing combination shots as a possible new kind of booster

The Independent UK

Man, 96, dies after allergic reaction to Covid-19 vaccine, inquest hears

An inquest report from the Rutland and North Leicestershire Coroner's Office says resuscitation was attempted at the scene , but he was confirmed dead on arrival at hospital by medical staff

Daily Mirror

Biden admin to promote availability of COVID antiviral pill

President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed

The Independent UK

Looking for Value Stocks to Add to Your Portfolio? Here are 5 For Your List

Heightened inflationary pressure, deepening supply chain disruptions, and the possibility of aggressive interest rate hikes later this year have fostered a volatile stock market. Because these factors are not expected to abate anytime soon, we think investors looking to generate solid long-term returns could consider betting on the stocks of…

StockNews.com

Pfizer's COVID pill is poised to be among the fastest-selling treatments of all time

Demand for Covid pills is set to make Pfizer Inc.’s Paxlovid among the fastest-selling treatments of all time, with revenue of almost $24 billion expected in 2022, according to a forecast from analytics group Airfinity Ltd.

Tribune News Service

If You Invested $1,000 In BioNTech Stock At Its Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

WHO 'Strongly Recommends' Pfizer's Covid Pill

The World Health Organization said Friday it "strongly recommended" Pfizer's Covid-19 antiviral pill Paxlovid for patients with milder forms of the disease who were still at a high risk of hospitalization. However the UN agency warned it was "extremely concerned" that the inequality in access seen with Covid vaccines would…

Asharq Al-Awsat

Get all your
news in one place.

100's of premium titles.
One news app.

Al Jazeera

‘Best therapeutic choice’: WHO backs Pfizer’s COVID antiviral

UN health body says Paxlovid ‘strongly recommended’ for patients with non-severe disease at risk of hospital admission.

Benzinga

If You Invested $1,000 In Pfizer Stock At Its Pandemic Low, Here's How Much You'd Have Now

Manchester Evening News

Latest data shows significant rise in Covid deaths in England and Wales for third week in a row

Deaths involving Covid-19 are up 13 per cent on last week, the latest data shows

Wales Online

Covid booster gives long-lasting protection, study finds

'The longer-term protection against hospitalisation and death is perhaps the most important factor for future booster programmes'

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Third Covid-19 vaccine dose offers ‘prolonged immune response’ – UK-wide study

The study compared immune responses to seven vaccines used as a booster 28 days after two initial doses.

Benzinga

Pfizer Whale Trades For April 20

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 21 strange trades.

The Conversation

The Valneva COVID vaccine has been approved for use in the UK – here's what the evidence says

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new COVID vaccine. VLA2001 is manufactured by French pharmaceutical company Valneva for use in the UK and was approved on April 14 for use in adults between the ages of 18 and 50 for first and second doses.

Axios

Parents of kids under 5 still waiting for COVID shots

The demise of the federal transportation mask mandate was particularly jarring for many parents of children under five anxiously waiting for word on when COVID shots will become available to their kids.

Tribune News Service

Moderna says redesigned COVID-19 vaccine booster may work better against variants

Moderna’s updated COVID-19 booster shot shows even more efficiency against variants, the pharmaceutical company announced Tuesday, citing preliminary results from a trial.

Benzinga

Read Why Demand For Pfizer's COVID-19 Antiviral Therapy Is Unexpectedly Low: Reuters

Global demand for Pfizer Inc's (NYSE: PFE) Paxlovid has been unexpectedly light due to complicated eligibility requirements, reduced testing, and potential for drug interactions, a

Evening Standard

Covid vaccination technology may be used as first heart attack ‘cure’

Protein produced by genetic code, mRNA, can create healthy new heart cells

1 … 57 58 59 60

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.